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Neuronal differentiation is triggered by a
change in TRF2 splice forms from full-
length (FL) to short (S). Grammatikakis
et al. find that the RNA-binding protein
and splicing regulator HNRNPH prevents
this switch, elevating TRF2-FL and
inhibiting neurogenesis in rat.
Accordingly, HNRNPH silencing leads to
accumulation of TRF2-S and enhances
neuronal differentiation.
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During neuronal differentiation, use of an alternative
splice site on the rat telomere repeat-binding factor
2 (TRF2) mRNA generates a short TRF2 protein iso-
form (TRF2-S) capable of derepressing neuronal
genes. However, the RNA-binding proteins (RBPs)
controlling this splicing event are unknown. Here,
using affinity pull-down analysis, we identified
heterogeneous nuclear ribonucleoproteins H1 and
H2(HNRNPH) as RBPs specifically capable of inter-
acting with the spliced RNA segment (exon 7) of Trf2
pre-mRNA. HNRNPH proteins prevent the production
of the short isoform of Trf2 mRNA, as HNRNPH
silencing selectively elevates TRF2-S levels. Accord-
ingly, HNRNPH levels decline while TRF2-S levels
increase during neuronal differentiation. In addition,
CRISPR/Cas9-mediated deletion of hnRNPH2 se-
lectively accelerates theNGF-triggered differentiation
of rat pheochromocytoma cells into neurons. In sum,
HNRNPH is a splicing regulator of Trf2pre-mRNA that
prevents the expression of TRF2-S, a factor impli-
cated in neuronal differentiation.
INTRODUCTION
The protein telomeric repeat-binding factor 2 (TRF2, also known
as TERF2 and TRBF2) was originally identified as part of a
protein complex named shelterin that protects telomeres, the
regions at the ends of chromosomes (de Lange, 2005). Extra-te-
lomeric functions for TRF2 have also emerged. In differentiating
human embryonic stem cells, increased TRF2 levels promote the
expression of REST (repressor element-1 silencing transcription
factor), a negative regulator of neuronal genes; conversely, TRF2
inhibition in rodents promotes neuronal differentiation (Schoen-
herr and Anderson, 1995; Ovando-Roche et al., 2014). A domi-
nant negative form of TRF2 triggered a DNA damage response
and senescence in mitotic neural cells, whereas TRF2 inhibition
enhanced differentiation of hippocampal neurons (Zhang et al.,
2006). TRF2 binds to REST and protects it from proteasomal926 Cell Reports 15, 926–934, May 3, 2016 ª2016 The Authors
This is an open access article under the CC BY-NC-ND license (http://degradation, causing repression of neuronal genes and inhibition
of neuronal differentiation (Zhang et al., 2008). In rodents, TRF2
inhibition promoted neuronal differentiation, whereas TRF2
depletion in patient glioblastoma stem cells reduced cell prolifer-
ation and increased expression of proteins targeted for repres-
sion by REST (Bai et al., 2014).
The gene that encodes TRF2 contains ten exons and is subject
to alternative splicing. Recently, a new isoform of TRF2 was
identified, TRF2-S; in rodents, TRF2-S arises when a 50 alterna-
tive splice site on exon 7 is used and only part of exon 7 (exon 7a)
in Trf2 pre-mRNA is included in the mature Trf2 mRNA (Zhang
et al., 2011). The resulting protein isoform lacks the DNA-binding
domain and nuclear localization signal (NLS) and instead pos-
sesses a short sequence that retains TRF2-S in the cytoplasm.
TRF2-S maintains the ability to bind to REST and renders it inac-
tive in the cytoplasm, in turn derepressing neuronal genes and
inducing differentiation of rat cortical neurons (Zhang et al.,
2011).
The spliceosome catalyzes exon joining and intron removal as
pre-mRNAs are processed into mature mRNAs (Wahl et al.,
2009). The vast majority of human genes that contain more
than one exon undergo alternative splicing with variable expres-
sion among tissues (Wang et al., 2008). Alternative splicing is a
major contributor to protein isoform diversity, because a single
precursor mRNA can give rise to multiple mRNA splice variants
(Cooper, 2005), depending on pre-mRNA sequences that act
as cis-acting elements around splice sites (Barash et al., 2010).
RNA-binding proteins (RBPs) that function as alternative splicing
regulators bind to pre-mRNA cis-acting elements and can
promote or repress spliceosome formation and thus regulate
alternative splice site usage in the mature transcript (Blencowe,
2006).
Previous studies have identified alternative splicing regulators
in neurons (Calarco et al., 2011), but the RBPs involved in regu-
lating TRF2 splicing and hence neuronal differentiation are
unknown. Here, through a proteomic screen, we identified
RBPs interacting with exon 7 of the Trf2 pre-mRNA. Two RBPs
of the heterogeneous nuclear ribonucleoprotein H (HNRNPH)
family were capable of binding and inhibiting the use of the
50 alternative splice site on exon 7, promoting inclusion of exon
7 of Trf2 pre-mRNA and thereby increasing the relative levels
of full-length (FL) TRF2 and lowering TRF2-S abundance.creativecommons.org/licenses/by-nc-nd/4.0/).
(legend on next page)
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CRISPR-mediated reduction of HNRNPH accelerated neuronal
differentiation, suggesting a critical role for HNRNPH as re-
pressor of neurogenesis.
RESULTS
Proteomic Screen Identifies HNRNPH among the
Proteins Binding to Trf2 Exon 7 RNA
TRF2-S is a short isoform of protein TRF2 that is produced
when an alternative 50 splice site of exon 7 is used and a
shorter segment of exon 7 is spliced into the mature Trf2
mRNA (Figure 1A; Zhang et al., 2011). A premature termination
codon is then created that produces TRF2-S (330 amino
acids [aa] long), shorter than the 500-aa long TRF2-F.
TRF2-S can still bind REST and renders REST inactive in the
cytoplasm, leading to neuronal gene derepression and neu-
ronal differentiation.
We sought to identify the RBPs controlling TRF2 50 alternative
splice site use and hence TRF2-S production. An 1-kb PCR
product from rat genomic DNA containing exon 7 plus flanking
sequences (300 nt in each direction; Figure 1B) was used as
a template for in vitro transcription of biotinylated RNA. Nuclear
extracts prepared from rat cerebellum and kidney (a control tis-
sue) were used for identifying RBPs binding to the biotinylated
RNA; a negative control RNA (biotinylated rat Gapdh 30 UTR)
was included. The80 proteins selectively bound to biotinylated
Trf2 RNA (Table S1) were further selected as explained (Supple-
mental Experimental Procedures). They included several RBPs
(e.g., ELAVL1 [HuR], ELAVL3 [HuC], RBM14, and RNA helicases
DDX17 and DDX5) and hnRNPs HNRNPH1 and HNRNPH2,
which were shown to modulate alternative splicing (Huelga
et al., 2012; Katz et al., 2010; Stark et al., 2011; Turunen et al.,
2013; Uren et al., 2016), HNRNPF, HNRNPA3, and HNRNPD0.
HNRNPF is functionally related to the HNRNPH family and was
shown to regulate splicing (Mandler et al., 2014; Wang et al.,
2012). Other RBPs identified in kidney extracts included Staufen
1 (STAU1) and the splicing regulator polypyrimidine tract-binding
protein 1 (PTB) (Boutz et al., 2007; Li et al., 2014). In summary, weFigure 1. Identification of Proteins Binding to and Regulating Trf2 Exo
(A) Schematic representation of the Trf2 gene and the isoforms produced by altern
Exon 7 contains three segments; inclusion of all segments produces Trf2-FLmRN
(B) Scheme of exon 7 and 300-nt flanking intronic sequences used in in vitro bindin
T7 promoter sequence was used to generate a PCR product suitable for in vitro tr
(C) After pull-down using streptavidin beads, interacting proteins were size-fractio
in the pull-downmaterials, those selectively enriched in cerebellum (top) and kidne
listed. Biotinylated rat Gapdh 30 UTR RNA was included as negative control.
(D) Schematic of the minigene used in the splicing assay. Exon 7 was cloned into
Cooper, 2006). Arrows, primers used to amplify the spliced segment; graph, 48 hr
RBP mRNA remaining compared with the scrambled siRNA transfection group.
(E–G) Acrylamide gels showing semi-qPCR products from the minigene (E, top) or
in which a given RBP identified by mass spectrometry was silenced using siRNA
conversion (Trf2-FL RNA relative to total Trf2 RNA bands) from the minigene (F)
(H–J) Forty-eight hours after transfecting PC12 cells with two different siRNAs for
HNRNPH levels (H) and acrylamide gels were used to visualize semi-qPCR produ
transfected with scrambled siRNA. The levels of conversion (Trf2-FL band rel
calculated (J).
(K) Forty-eight hours after transfecting PC12 cells with two different siRNAs for eac
the levels of Hnrnph1, Hnrnph2, Trf2-S, and Trf2-FLmRNAs; western blot analysi
In (D–G), (J), and (K), the data represent the means + SEM from at least three ex
928 Cell Reports 15, 926–934, May 3, 2016identified RBPs selectively binding to Trf2 exon 7 RNA in rat
cerebellar extracts (Figure 1C).
Fourteen RBPs that interacted selectively with Trf2 exon 7
RNA and might have a role in neuronal gene regulation were
studied for their influence on TRF2 alternative splicing using
an ex vivo functional splicing assay that employed the RNA
sequence used in the RNA affinity pull-down assay (Figure 1B)
cloned into a minigene (Figure 1D, top). Forty-eight hr after
transfection of rat pheochromocytoma PC12 cells with small
interfering (si)RNAs directed at each RBP, the degree of knock-
down achieved was measured by reverse transcription (RT)
followed by real-time, qPCR analysis of each RBP mRNA (Fig-
ure 1D, lower). The effect of each knockdown was then
assayed on Trf2 pre-mRNA splicing by RT followed by semi-
qPCR analysis using primers directed at the flanking exons
(‘‘minigene’’); similar primers were used to assay endogenous
Trf2 transcripts spanning exon 7a and exon 8 (‘‘endogenous’’;
Figures 1E–1G). Besides Trf2-FL and Trf2-S (observed at the
expected sizes), an intermediate-sized band was observed
that potentially corresponds to Trf2-S’ (Zhang et al., 2011). As
shown, the ratio of the Trf2-FL and Trf2-S isoform in the mini-
gene and endogenous transcript assays did not change signif-
icantly for the siRNAs tested, except when HNRNPH1 or H2
were knocked down, whereas HNRNPF did not have any effect
on Trf2 splicing (Figures 1E–1G). These results indicate that
HNRNPH proteins can potentially regulate TRF2 alternative
splicing.
HNRNPH1 and HNRNPH2 are >95% identical paralogs of the
HNRNPH RBP family. To test whether they might influence
splicing in similar ways, we used two different siRNAs directed
at each HNRNPH. As shown (Figures 1H–1J), by 48 hr after
transfection, all siRNAs lowered HNRNPH and shifted the ratio
of Trf2 toward the production of less Trf2-FL mRNA and more
Trf2-S mRNA (endogenous and minigene). A less efficient
HNRNPH2 knockdown led to a more modest Trf2 splicing,
whereas HNRNPH1 silencing lowered both H1 and H2, possibly
explaining why H1 siRNA more strongly favored splicing of
Trf2-S (Figures 1H–1K).n 7 Splicing
ative splicing of exon 7. Boxes indicate exons and straight lines depict introns.
A, whereas use of 50 alternative splice site produces Trf2-S and Trf2-S’mRNAs.
g assay with biotinylated RNA (red line). Primers are indicated with arrows; the
anscription. Incubations were carried out with kidney and cerebellum extracts.
nated by SDS-PAGE and analyzed by mass spectrometry. Among the proteins
y (bottom), along with the number of peptides found bymass spec analysis, are
a vector containing heterologous sequences for introns and exons (Singh and
after transfection of each siRNA, RBP silencing was determined by the levels of
endogenous gene (E, bottom); each lane represents a different cell population
; control cells transfected with scrambled siRNA were included. The levels of
or the endogenous gene (G) were calculated.
each HNRNPH or scrambled siRNA, western blot analysis was used to assess
cts from the minigene (I, left) or endogenous gene (I, right). Control cells were
ative to total Trf2 bands) from the minigene or the endogenous gene were
h HNRNPH or scrambled siRNA, RT-qPCRanalysis was performed tomeasure
s was performed to assess the levels of HNRNPH and loading control GAPDH.
periments; *p < 0.05.
(legend on next page)
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HNRNPH Binds Trf2 Pre-mRNA, Inhibits Splicing of
Exon 7, and Lowers TRF2-S Production
Given earlier evidence that HNRNPH associated with biotinylated
Trf2 RNA exon 7, we performed RIP (ribonucleoprotein [RNP]
immunoprecipitation [IP]) analysis to investigate this interaction
further. HNRNPH was immunoprecipitated from PC12 cell ex-
tracts, and its interaction with Trf2 RNA was measured by
RT-qPCR analysis employing two different sets of primers (Fig-
ure 2A). This interaction was measured as the enrichment in
Trf2 RNA in HNRNPH IP compared with immunoglobulin G (IgG)
IP; the levels of Tbp mRNA, encoding a housekeeping protein,
in each IP were used to normalize differences in sample input.
We then tested whether HNRNPH contributed to the use of the
alternative splice site of Trf2 pre-mRNA into protein; western
blot analysis with an antibody that recognized both isoforms re-
vealed that TRF2-S levels were higher and TRF2-FL lower after
silencing either HNRNPH1 or HNRNPH2 (Figures 2B and 2C).
Measurement of Trf2-FL and Trf2-S mRNAs on polysome gradi-
ents indicated that HNRNPH2 silencing did not influence the
translation of either protein isoform (not shown). In addition, acti-
nomycin D treatment of PC12 cells after silencing HNRNPH
showed that HNRNPH did not affect the stability of Trf2-S or
Trf2-FLmRNAstability (FigureS1). Collectively, these results sug-
gest that HNRNPH inhibits the use of an alternative splice site on
exon 7 and the production of the short transcript (Trf2-S) and fa-
vors production of the longer transcript (Trf2-FL); accordingly,
HNRNPH silencing induced TRF2-S protein production.
Tomap the site of interaction of HNRNPHwith Trf2 pre-mRNA,
the region surrounding exon 7 was divided into seven overlap-
ping fragments, each 150 nt in length (Figure 2D, top). Biotin
pull-down analysis using whole-cell extracts from PC12 cells
showed that HNRNPH associated with fragments 2 and 4 (Fig-
ure 2D, bottom); further subdivision of these RNAs into 30-nt
fragments showed that F2-5, F4-4, and F4-5 contained binding
sequences for HNRNPH (Figure 2E). Previous studies character-
ized the binding sequence of HRNPH1 as 5- to 8-nt-long
sequence rich in Gs and As (Huelga et al., 2012; Uren et al.,
2016). When sequences F2-5, F4-4, and F4-5 were mutated
into stretches of Us, biotin pull-down analysis showed that bind-
ing was abolished (Figure 2F). In all assays, negative controls
(biotinylated rat Gapdh 30 UTR and beads only) were included
(Figures 2D–2F).Figure 2. HNRNPH Proteins Bind to Exon 7 and Regulate Trf2 Exon 7 S
(A) RIP analysis tomeasure the enrichment of Trf2mRNA (and input control TbpmR
IP. Two different sets of primers were used: one spanning exons 5 and 6 (left) an
(B andC) Forty-eight hours after transfecting PC12 cells with scrambled, HNRNPH
HNRNPH (B) and TRF2-FL and TRF2-S (C). Anti-HNRNPH antibody recognized bo
ratios of TRF2-FL to total TRF2 after quantification by densitometry.
(D) Exon 7 and flanking intronic sequences used to identify the binding sites of H
above the schematic). Smaller (30-nt-long) subfragments of fragments 2 and 4 are
was used to identify the biotinylated RNAs associating with HNRNPH (fragments
(E) Similar biotin pull-down analysis using subfragments 1–6 from fragments 2 an
(F) Sequences of the three putative sites binding to HNRNPH. The red underlined s
biotin pull-down analysis of HNRNPH binding subfragments F2-5, F4-4, and F4-5
beads only were used as negative controls.
(G) Acrylamide gels showing the PCR products from theminigene (wild-type [WT])
F4-5 mut). Each minigene was assayed in cells transfected with scrambled siRN
mRNA relative to total Trf2 mRNA) from the minigene. Data represent the means
930 Cell Reports 15, 926–934, May 3, 2016We then examined whether these binding sites influenced the
use of an alternative splice site by HNRNPH. We inserted the
same mutations that abolish binding (Figure 2F) into the mini-
genes that were used as Trf2 splicing reporters (Figure 1) and
conducted splicing assays in PC12 cells that had been trans-
fected with scrambled siRNA, or with siRNAs directed at
HNRNPH1 or H2. As shown (Figure 2G), knockdown of either
HNRNPH1 or H2 lowered Trf2-FL and elevated Trf2-S, suggest-
ing that all three binding sitesmay regulate HNRNPHbinding and
Trf2 splicing. The minigene with the mutated F4-4 sequence
showed lower basal level of inclusion (scrambled siRNA),
indicating that this site may have a stronger effect on HNRNPH
regulation of Trf2 splicing, whereas for the minigene with
mutated F4-5 sequence, the basal levels of inclusion increased,
likely because a cis element promoting Trf2-S was disrupted by
the mutation. Collectively, these results indicate that HNRNPH
can bind to three distinct binding sites near or on exon 7 and
potentially all of them play a role in regulation of Trf2 splicing.
HNRNPH Levels Decrease during Neuronal
Differentiation
TRF2-S was recently shown to play a role in neuronal differenti-
ation. Because TRF2-S contributes to REST inactivation and rat
cortical neuron differentiation, a factor that regulates TRF2-S
abundance may also coordinate neuronal differentiation. To
test whether HNRNPH plays a role in this process, we examined
HNRNPH expression levels at different times during differentia-
tion of rat cortical neurons. We observed a gradual decrease in
the levels of HNRNPH (Figure 3A), in the absence of comparable
changes inHnrnph1 andHnrnph2mRNAs (Figure 3B, top); at the
same time, there was a gradual increase in TRF2-S protein, as
reported earlier (Zhang et al., 2011), and decrease in TRF2-FL
(Figure 3A). A gradual increase of Trf2-S mRNA and decrease
of Trf2-FL mRNA was also observed (Figure 3B, bottom).
In another model of neuronal differentiation, treatment of PC12
cells with NGF in the presence of low serum triggers their differ-
entiation into neurons in 7–10 days, with formation of neurites
(Das et al., 2004). Here too, during NGF-triggered differentiation,
HNRNPH levels decreased gradually (Figure 3C), Hnrnph1
and Hnrnph2 mRNAs decreased only moderately, and there
was a gradual increase of Trf2-S and decrease of Trf2-FL
(Figure 3D). These findings indicate that HNRNPH proteins areplicing
NA [TATA-binding protein]) by RT-qPCR analysis in HNRNPH IP relative to IgG
d the other spanning exons 6 and 7 (right).
1, or HNRNPH2 siRNAs, western blot analysis was used to analyze the levels of
th isoforms; the levels of GAPDHwere assessed to monitor loading; graph (C),
NRNPH (top). Large (150-nt-long) fragments were tested first (horizontal lines
shown. Red fragments indicate binding. After incubation, western blot analysis
2 and 4).
d 4.
equences indicate the potential binding sites that weremutated into Us. Lower:
and correspondingmutants is shown. In (D)–(F), biotinylatedGapdh 30 UTR and
andminigenes each containing amutated binding site (F2-5mut, F4-4mut, and
A, HNRNPH1 siRNA, or HNRNPH2 siRNA. Graph, conversion ratios (Trf2-FL
+ SEM from at least three experiments; *p < 0.05.
Figure 3. HNRNPH Levels Decline during
Neuronal Differentiation
(A and B) Primary rat cortical neurons from em-
bryonic day 14 were cultured in differentiation
media; at the times indicated, western blot analysis
was performed to monitor the levels of HNRNPH,
TRF2-FL, TRF2-S, and loading control GAPDH.
Graph, % conversion (ratios of TRF2-FL relative to
total TRF2) during differentiation (A). RT-qPCR
analysis to measure the levels of Hnrnph1,
Hnrnph2, Trf2-S, and Trf2-FL mRNAs in differen-
tiating neurons compared to undifferentiated
neurons (neural stem cells) is shown.
(C and D) During differentiation of PC12 cells in
the presence of NGF, the levels of HNRNPH and
loading control TUBB (b-tubulin) were measured
by western blot analysis; because TUBB levels
changed, a photograph of the western blot mem-
brane stained with Ponceau S red was included
(C). RT-qPCR analysis of the levels of Hnrnph1,
Hnrnph2, Trf2-S, and Trf2-FLmRNAs compared to
untreated cells is shown (D).
In (B) and (D), data represent the means + SEM
from at least three experiments.downregulated during rat neuronal differentiation and suggest
an inhibitory role for HNRNPH in this process.
HNRNPH Regulates Neuronal Differentiation
Several RBPs have been linked to neuronal differentiation (Cal-
arco et al., 2011; Grabowski, 2011). Because HNRNPH inhibits
TRF2-S production and HNRNPH levels decrease during differ-
entiation, we hypothesized that HNRNPHmay have an inhibitory
influence on neuronal differentiation. To investigate this possibil-
ity, we reduced HNRNPH2 levels and studied whether neuronal
differentiation progressed at a different rate. Unfortunately,
HNRNPH siRNA transfections were transient and thus unable
to maintain reduced HNRNPH levels for extended time periods
(not shown). Therefore, CRISPR technology was employed to
lower HNRNPH2 levels. PC12 cells expressing Cas9 and guide
(g)RNA targeting Hnrnph2 were generated by lentiviral infection.
The transduced cells expressed a puromycin resistance gene for
selection and a GFP reporter gene for identification of
cells expressing the transgene (Figure 4A). Western blotanalysis confirmed the downregulation
of HNRNPH and the switch in the ratio of
TRF2-FL and TRF2-S levels (Figure 4B);
RT-qPCR analysis verified the decline in
Hnrnph2 mRNA levels (Figure 4C, top)
and the change in the Trf2-S and Trf2-FL
mRNA levels (Figure 4C, bottom). After
treating the cells with differentiation me-
dia, cells with reduced HNRNPH2 levels
showed accelerated differentiation rela-
tive to control cells; these changes were
observed at different days, including day
6 (Figure 4D). Differentiated cells were
counted if there was at least one neurite
extension that was at least twice thediameter of the cell body. As shown, significantly more cells
differentiated in the CRISPR-HNRNPH2 populations (Figure 4E).
Analysis of clonal populations (Figure S2A) showed that differ-
entiation was consistently accelerated in cells with reduced
HNRNPH2 than in control cells. Collectively, these data
support the hypothesis that HNRNPH inhibits neuronal
differentiation.
DISCUSSION
Alternative splicing is a major contributor to protein isoform di-
versity and explains the fact that the number of human genes
is much lower than the number of distinct proteins expressed
in a given cell (Nilsen and Graveley, 2010). Here, we identified
HNRNPH as a regulator of Trf2 alternative splicing that inhibits
the production of the shorter protein isoform, TRF2-S. The con-
sequences of this regulation were studied in two models of
neuronal differentiation: rat PC12 cells treated with NGF and
neurogenesis of rat primary cortical neurons. In both systems,Cell Reports 15, 926–934, May 3, 2016 931
Figure 4. Inhibiting HNRNPH2 Promotes
Neuronal Differentiation of PC12 Cells
(A) Phase contrast and fluorescence (GFP) micro-
graphs of pooled PC12 populations with CRISPR/
Cas9 directed at HNRNPH2; virtually 100% of cells
expressed GFP.
(B and C) In uninfected or CRISPR-virus-infected
cells described in (A), western blot analysis was
used to measure the levels of HNRNPH2, loading
control GAPDH, TRF2-FL, and TRF2-S (B), and
RT-qPCR analysis was used to measure the levels
of Hnrnph2, Trf2-FL, and Trf2-S mRNAs (C).
(D) Representative micrographs of uninfected and
CRISPR-HNRNPH2 virus-infected PC12 cells
shown in (A) before and after differentiation (NGF
for 6 days).
(E) Graph represents the percentage of differenti-
ated PC12 cells (cells with at least one neurite
extension that was at least twice as long as the
diameter of the cell body).
Data represent the means + SEM from four ex-
periments; *p < 0.05.differentiation triggered a gradual decrease of HNRNPH levels
concomitant with an increase in Trf2-S. Importantly, inhibition
of HNRNPH2 in PC12 cells using CRISPR accelerated neuronal
differentiation.
Previous studies have identified several alternative splicing
regulators implicated in neuronal cell differentiation (Calarco
et al., 2011). A characteristic example is the neuronal-specific
RBP NOVA, which binds RNA (Licatalosi et al., 2008; Ule et al.,
2006) and regulates splicing of genes encoding synaptic pro-
teins (Irimia et al., 2011; Zhang et al., 2010). During neuronal
differentiation, reprogramming of alternative splicing events de-
pends on the switch in the expression of PTB to the isoform
nPTB, which is neuronal specific (Boutz et al., 2007). This switch
is responsible for reprogramming a network of alternative
splicing events in the developing neurons implicated in neuronal
maturation (Boutz et al., 2007; Li et al., 2014). Another RBP,
nSR100, regulates brain-specific alternative exons enriched in
genes related to neural differentiation, and its inhibition disrupts
neural cell differentiation in culture in developing zebrafish (Cal-
arco et al., 2009).
The splicing regulator involved in neuronal differentiation
described here, HNRNPH, belongs to a family of hnRNPs origi-
nally identified to regulate splicing (Martinez-Contreras et al.,
2007) that contain RRM or KH RNA-binding domains. Several
high-throughput studies have characterized the role of HRNPH1
in splicing, mRNA stability, and polyadenylation (Huelga et al.,
2012; Katz et al., 2010; Uren et al., 2016; Wang et al., 2012).
The most recent of these studies identified a CLIP tag on the hu-
man homolog of Trf2 (Uren et al., 2016) and identified potential932 Cell Reports 15, 926–934, May 3, 2016binding sites as G tracts containing As
(Huelga et al., 2012; Uren et al., 2016).
HNRNPH1 was previously shown to regu-
late alternative splicing in oligodendro-
cytes (Mandler et al., 2014; Wang et al.,
2012) and exon inclusion of several tran-
scripts encoding brain-specific proteinsC1 cassette exon of the glutamate NMDA R1 receptor (GRIN1)
mRNA (Han et al., 2005) and was proposed to promote c-Src
N1 exon inclusion in neuronal cells (Chou et al., 1999) and
exon 2 inclusion on the OPRM1 (m opioid receptor; Xu et al.,
2014). REST is also regulated via alternative splicing (Chen and
Miller, 2013); interestingly, HNRNPH1 regulates the neuronal-
specific exon N of REST in H69 small-cell lung cancer cells
and is a pre-requisite for binding of the splicing factor U2AF65
and subsequent exon inclusion (Ortun˜o-Pineda et al., 2012).
Together with our findings, these studies underscore the impor-
tance of HNRNPH1 in controlling alternative splicing of neural
genes.
By contrast, the paralog HNRNPH2 has not been studied
extensively. Its role in alternative splicing was previously
described for thymidine phosphorylase (TP), where binding of
HNRNPH2 to the TP pre-mRNA caused intron retention and
repression of TP translation leading to anti-cancer drug resis-
tance due to loss of TP (Stark et al., 2011). In addition, HNRNPH2
was shown to interact with CUG repeats, implicated in myotonic
dystrophy (DM), andwas later identified as a regulator of exon 11
of the insulin receptor gene, an alternative splicing event that is
misregulated in DM (Paul et al., 2011). Whereas this study impli-
cates HNRNPH1 in neuronal differentiation, its functions may
overlap with those of HNRNPH2, because the two proteins
are >95% identical. As shown, the U12-dependent spliceosome
component U11-48K is regulated by binding of HNRNPH1 and
HNRNPH2 to a stretch of Gs of the U11-48K pre-mRNA to
induce skipping of exon 4i and protect the mRNA from
nonsense-mediated decay (NMD) (Turunen et al., 2013).
The binding sites for HNRNPH on near exon 7 were identified
experimentally (Figure 2) and guided by previous studies (Huelga
et al., 2012; Uren et al., 2016). Mutating the sites into stretches of
Us abolished binding, even though it did not fully prevent
splicing, suggesting that there are additional sites through which
HNRNPH regulates splicing, that the three sites are partially
redundant, or that HNRNPH does not inhibit the use of the alter-
native splice site but rather promotes the use of the downstream
site. Multiple simultaneous disruptions of HNRNPH sites on the
minigene were not tested, as excessive modification of the
splicing site would have rendered the splicing data inconclusive.
In addition, whereas HNRNPH regulation on splicing was linked
to the closely related protein HNRNPF (Mandler et al., 2014;
Wang et al., 2012), HNRNPF had no effect on Trf2 splicing (Fig-
ure 1); whether the two proteins synergize in this context was not
examined.
Both paralogs control splicing of Trf2-S, although HNRNPH1
appeared to have a stronger splicing effect in suppressing
TRF2-S. Unexpectedly, CRISPR/Cas9 successfully downregu-
lated HNRNPH2 but did not yield any clones in which HNRNPH1
was downregulated, despite numerous attempts. Perhaps cells
with efficientHNRNPH1 downregulationmay differentiate sponta-
neously and thus stop dividing, precluding clonal expan-
sion. HNRNPH protein levels were profoundly downregulated
whereas Hnrnph1 and Hnrnph2 mRNAs were not (Figure 3) and
didnot appear tobesubject toaltered turnover (FigureS1), despite
the presence of a premature termination codon in exon 8 of the
shorter isoform of Trf2 (Zhang et al., 2011), which might trigger
NMD. These findings led us to propose that HNRNPH protein
levels in neuronal tissues are tightly regulated at the level of trans-
lation or protein stability. Possibly for these reasons, our attempts
to overexpress HNRNPH were also unsuccessful (not shown).
In sum, we have identified HNRNPH as a factor that represses
neuronal differentiation at least in part by inhibiting the alternative
splicing of TRF2 into the pro-differentiation isoform TRF2-S.
Given that almost certainly other RNA targets of HNRNPH also
contribute to preventing neuronal differentiation, identifying
these additional effectors is warranted, whether HNRNPH
influences splicing or other post-transcriptional processes. Con-
versely, other splicing factors that our screen may have missed
may also cooperate with HNRNPH to regulate TRF2 splicing.
Further studies employing the approaches outlined here will
help us understand comprehensively the impact of HNRNPH
and TRF2 upon neuronal differentiation.EXPERIMENTAL PROCEDURES
RNA Analysis
The oligomers and conditions used for in vitro transcription, preparation of bio-
tinylated RNA, and RNA pull-down assays are indicated in the Supplemental
Experimental Procedures. The minigene cloning and splicing assay were
carried out as described (Singh and Cooper, 2006) using the primers listed
in Table S2. RIP analysis was carried out as reported earlier (Abdelmohsen
et al., 2012), and RT followed by conventional PCR and by real-time qPCR an-
alyses are explained (Supplemental Experimental Procedures).Protein Analysis
The preparation of cerebellum and kidney extracts, as well as the mass spec-
trometry details, is in the Supplemental Experimental Procedures.Western blotanalysis was performed using standard methods, and protein signals were de-
tected using the antibodies listed (Supplemental Experimental Procedures).
Cell Culture, Differentiation, Transfection, and CRISPR/Cas9
Rat cortical neurons were extracted from rat embryos on E17 as described
previously (Zhang et al., 2011), and PC12 cells were cultured as explained in
the Supplemental Experimental Procedures. Transfections were carried
out using polyethylenimine (Sigma-Aldrich; PEI) and Lipofectamine; siRNA se-
quences directed at different proteins are listed in Table S3.
To study differentiation of primary neurons, neurobasal media containing
B27 supplement (Gibco) was used. To generate stable PC12 cells, we used
a CRISPR/Cas9 vector (Sigma-Aldrich) targeting the sequence ACTTTCA
GGGGCGGAGCACAGG.
Statistical Analysis
Data are presented asmeans ± SEM. Significance was tested using two-tailed
Student’s t test. p < 0.05 was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.03.080.
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